TNXT — T ROWE PRICE EXCHANGE-TRADED
As of Q2 2026, 1 SEC-registered investment managers reported holding TNXT (T ROWE PRICE EXCHANGE-TRADED) in their latest 13F filings, with a combined reported value of $443.92K across 15.89K shares. That is +47.6% by share count (+5.12K shares) versus the previous quarter, while reported value moved +83.0%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 1 added to existing stakes, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Q2 2026 — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Citadel Advisors history | 15.89K | $443.92K | 0.00% | Add |
Q1 2026 — 2 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Citadel Advisors history | 10.57K | $238.21K | 0.00% | New |
| UBS Group AG history | 196 | $4.42K | 0.00% | New |
New Positions (Q2 2026)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
- UBS Group AG sold 196 sh · $4.42K
Fund Position History — shares by quarter (top 2 funds)
| Fund | Q2 2026 | Q1 2026 |
|---|---|---|
| Citadel Advisors | 15.89K | 10.57K |
| UBS Group AG | — | 196 |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details